Europe Biosimilars Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Europe Biosimilars Market Snapshot 2026 and 2033
   2. Market Opportunity Assessment, 2026-2033, US$ Mn
   3. Key Market Trends
   4. Industry Developments and Key Market Events
   5. Demand Side and Supply-Side Analysis
   6. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definitions
   2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
   3. Macro-Economic Factors
      1. Europe GDP Outlook
      2. Europe Prison Growth Outlook
   4. Forecast Factors – Relevance and Impact
   5. COVID-19 Impact Assessment
3. Value Added Insights
   1. Value Chain analysis
   2. Key Market Players
   3. Product Adoption Analysis
   4. Key Promotional Strategies by key players
   5. PESTLE Analysis
   6. Porter's Five Forces Analysis
   7. Regulatory and Technology Landscape
4. Europe Biosimilars Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
   1. Key Highlights
   2. Europe Biosimilars Market Outlook: Drug
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Drug, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Drug, 2026-2033
         1. Adalimumab
         2. Bevacizumab
         3. Trastuzumab
         4. Rituximab
         5. Infliximab
         6. Etanercept
         7. Epoetin alfa
         8. Filgrastim
         9. Other
      4. Market Attractiveness Analysis: Drug
   3. Europe Biosimilars Market Outlook: Drug Class
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Drug Class, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Drug Class, 2026-2033
         1. Antirheumatics
         2. TNF Alfa Inhibitors
         3. VEGF/VEGFR Inhibitors
         4. HER2 Inhibitors
         5. Selective Immunosuppressant’s
         6. Interleukin Inhibitors
      4. Market Attractiveness Analysis: Drug Class
   4. Europe Biosimilars Market Outlook: Indication
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Indication, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Indication, 2026-2033
         1. Oncology Diseases
         2. Autoimmune Diseases
         3. Skin Disorders
         4. Inflammatory Bowel Disease (IBD)
         5. Rare Diseases
         6. Others
      4. Market Attractiveness Analysis: Indication
   5. Europe Biosimilars Market Outlook: Distribution Channel
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2020-2025
      3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2026-2033
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Europe Biosimilars Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis by Country, 2020-2025
   3. Current Market Size (US$ Mn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Market Attractiveness Analysis: Region
6. Competition Landscape
   1. Market Share Analysis, 2025
   2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
   3. Company Profiles
      1. Fresenius Kabi
         1. Company Overview
         2. Product Portfolio/Offerings
         3. Key Financials
         4. SWOT Analysis
         5. Company Strategy and Key Developments
      2. Biogen Inc.
      3. Celltrion, Inc.
      4. Pfizer Inc.
      5. Amgen Inc.
      6. Samsung Bioepis Co., Ltd.
      7. Biocon
      8. Viatris (Mylan Pharmaceuticals Inc.)
      9. Coherus BioSciences, Inc.
      10. Boehringer Ingelheim Pharmaceuticals, Inc.
      11. Eli Lilly and Company
      12. Bio-Thera Solutions, Ltd.
      13. Others
7. Appendix
   1. Research Methodology
   2. Research Assumptions
   3. Acronyms and Abbreviations